{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:32:19Z","timestamp":1793413939550,"version":"4.5.0"},"reference-count":218,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.autrev.2020.102618","type":"journal-article","created":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T01:45:04Z","timestamp":1594518304000},"page":"102618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":147,"title":["2020 international consensus on ANCA testing beyond systemic vasculitis"],"prefix":"10.1016","volume":"19","author":[{"given":"Sergey","family":"Moiseev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Willem","family":"Cohen Tervaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Arimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios P.","family":"Bogdanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Csernok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Damoiseaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ferrante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Felipe","family":"Flores-Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin J.","family":"Fritzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Invernizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Jayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Charles","family":"Jennette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"McAdoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Novikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles D.","family":"Pusey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Radice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"Savige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e5rten","family":"Segelmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato A.","family":"Sinico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Jos\u00e9","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Specks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Terrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios G.","family":"Tzioufas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severine","family":"Vermeire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Bossuyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.autrev.2020.102618_bb0005","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrrheum.2017.140","article-title":"Position paper: Revised 2017 international consensus on testing of ANCA in granulomatosis with polyangiitis and microscopic polyangiitis","volume":"13","author":"Bossuyt","year":"2017","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2020.102618_bb0010","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.autrev.2017.11.014","article-title":"et al; French Vasculitis Study Group. Childhood- versus adult-onset ANCA-associated vasculitides: A nested, matched case-control study from the French Vasculitis Study Group Registry","volume":"17","author":"Iudici","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102618_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2018.02.016","article-title":"Testing and reporting antineutrophil cytoplasmic antibodies (ANCA) in treated vasculitis and non-vasculitic disease","volume":"458","author":"Savige","year":"2018","journal-title":"J Immunol Methods"},{"issue":"4","key":"10.1016\/j.autrev.2020.102618_bb0020","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/ajcp\/111.4.507","article-title":"International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA)","volume":"111","author":"Savige","year":"1999","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.autrev.2020.102618_bb0025","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1309\/WAEPADW0K4LPUHFN","volume":"120","author":"Savige","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.autrev.2020.102618_bb0030","first-page":"47","article-title":"Detection of anti-neutrophil cytoplasmic antibodies (ANCA) by indirect immunofluorescence","volume":"2019","author":"van Beers","year":"1901","journal-title":"Methods Mol Biol"},{"issue":"7","key":"10.1016\/j.autrev.2020.102618_bb0035","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.autrev.2016.03.010","article-title":"Evaluation of automated multi-parametric indirect immunofluorescence assays to detect anti-neutrophil cytoplasmic antibodies (ANCA) in granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA)","volume":"15","author":"Csernok","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102618_bb0040","first-page":"153","article-title":"Antigen-specific detection of autoantibodies against myeloperoxidase (MPO) and proteinase 3 (PR3)","volume":"2019","author":"Vanderlocht","year":"1901","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.autrev.2020.102618_bb0045","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40064-015-0835-8","article-title":"Association of ANCA associated vasculitis and rheumatoid arthritis: a lesser recognized overlap syndrome","volume":"4","author":"Draibe","year":"2015","journal-title":"Springerplus"},{"issue":"2","key":"10.1016\/j.autrev.2020.102618_bb0050","doi-asserted-by":"crossref","first-page":"58","DOI":"10.15171\/jnp.2017.10","article-title":"MPO-ANCA-associated necrotizing glomerulonephritis in rheumatoid arthritis; a case report and review of literature","volume":"6","author":"G\u00f3is","year":"2017","journal-title":"J Nephropathol"},{"key":"10.1016\/j.autrev.2020.102618_bb0055","doi-asserted-by":"crossref","first-page":"80","DOI":"10.12659\/AJCR.883841","article-title":"Appearance of ANCA associated vasculitis under tumor necrosis factor-alpha inhibitors treatment","volume":"14","author":"Reitblat","year":"2013","journal-title":"Am J Case Rep"},{"issue":"5","key":"10.1016\/j.autrev.2020.102618_bb0060","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.berh.2008.09.008","article-title":"Autoimmune diseases induced by TNF-targeted therapies","volume":"22","author":"Ramos-Casals","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102618_bb0065","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1172\/JCI103987","article-title":"Fluorescent antiglobulin studies in leukopenic and related disorders","volume":"38","author":"Calabresi","year":"1959","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.autrev.2020.102618_bb0070","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2249.1991.tb05779.x","article-title":"Anti-neutrophil cytoplasm antibodies in rheumatoid arthritis","volume":"86","author":"Savige","year":"1991","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2020.102618_bb0075","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0002-9343(92)90202-M","article-title":"Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders","volume":"93","author":"Kallenberg","year":"1992","journal-title":"Am J Med"},{"issue":"25","key":"10.1016\/j.autrev.2020.102618_bb0080","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM198806233182504","article-title":"Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis","volume":"318","author":"Falk","year":"1988","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.autrev.2020.102618_bb0085","first-page":"826","article-title":"Incidence, target antigens, and clinical implications of antineutrophil cytoplasmic antibodies in rheumatoid arthritis","volume":"23","author":"Braun","year":"1996","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2020.102618_bb0090","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/art.1780400417","article-title":"Perinuclear antineutrophil cytoplasmic antibody in rheumatoid arthritis","volume":"40","author":"Mustila","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2020.102618_bb0095","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/1529-0131(200006)43:6<1371::AID-ANR22>3.0.CO;2-R","article-title":"Antineutrophil cytoplasmic antibodies in patients with early rheumatoid arthritis: an early marker of progressive erosive disease","volume":"43","author":"Mustila","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2020.102618_bb0100","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/rheumatology\/39.5.481","article-title":"Prospective evaluation of the frequency and clinical significance of antineutrophil cytoplasmic and anticardiolipin antibodies in community cases of patients with rheumatoid arthritis","volume":"39","author":"Vittecoq","year":"2000","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.autrev.2020.102618_bb0105","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/ard.60.5.459","article-title":"Prevalence and clinical significance of antikeratin antibodies and other serological markers in Lithuanian patients with rheumatoid arthritis","volume":"60","author":"Vasiliauskiene","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2020.102618_bb0110","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/ard.53.1.24","article-title":"Anti-myeloperoxidase antibodies in patients with rheumatoid arthritis: prevalence, clinical correlates, and IgG subclass","volume":"53","author":"Cambridge","year":"1994","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.autrev.2020.102618_bb0115","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/art.1780360805","article-title":"Antineutrophil cytoplasmic antibodies in rheumatoid arthritis: characterization and clinical correlations","volume":"36","author":"Mulder","year":"1993","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2020.102618_bb0120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/s10165-010-0356-9","article-title":"Antineutrophil cytoplasmic antibodies against myeloperoxidase, proteinase 3, elastase, cathepsin G and lactoferrin in Japanese patients with rheumatoid arthritis","volume":"21","author":"Kida","year":"2011","journal-title":"Mod Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2020.102618_bb0125","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/ki.2010.472","article-title":"New pathophysiological insights and treatment of ANCA-associated vasculitis","volume":"79","author":"Wilde","year":"2011","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.autrev.2020.102618_bb0130","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.autrev.2017.12.002","article-title":"Cellular immune regulation in the pathogenesis of ANCA-associated vasculitides","volume":"17","author":"von Borstel","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.autrev.2020.102618_bb0135","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.autrev.2019.06.011","article-title":"An emerging role of neutrophils and NETosis in chronic inflammation and fibrosis in systemic lupus erythematosus (SLE) and ANCA-associated vasculitides (AAV): Implications for the pathogenesis and treatment","volume":"18","author":"Frangou","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2020.102618_bb0140","doi-asserted-by":"crossref","first-page":"102424","DOI":"10.1016\/j.autrev.2019.102424","article-title":"Complement alternative pathway in ANCA-associated vasculitis: Two decades from bench to bedside","volume":"19","author":"Brilland","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"22","key":"10.1016\/j.autrev.2020.102618_bb0145","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003748","article-title":"Systemic lupus erythematosus and antineutrophil cytoplasmic antibody-associated vasculitis overlap syndrome in patients with biopsy-proven glomerulonephritis","volume":"95","author":"Jarrot","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2020.102618_bb0150","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/978-1-4757-9182-2_37","article-title":"Perinuclear antineutrophil cytoplasmic antibodies (p-ANCA): clinical significance and relation to antibodies against myeloid lysosomal enzymes","volume":"336","author":"Tervaert","year":"1993","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"10.1016\/j.autrev.2020.102618_bb0155","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/art.1780380509","article-title":"Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Prevalence, specificities, and clinical significance","volume":"38","author":"Schnabel","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2020.102618_bb0160","first-page":"541","article-title":"Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. European Concerted Action on the Immunogenetics of SLE","volume":"16","author":"Galeazzi","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2020.102618_bb0165","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1191\/0961203303lu456rr","article-title":"Antineutrophil cytoplasmic autoantibodies in systemic lupus erythematosus","volume":"12","author":"Sen","year":"2003","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.autrev.2020.102618_bb0170","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/ki.2009.136","article-title":"Clinicopathological characteristics and outcomes of patients with crescentic lupus nephritis","volume":"76","author":"Yu","year":"2009","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.autrev.2020.102618_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2017.04.029","article-title":"Positive antineutrophil cytoplasmic antibody serology in patients with lupus nephritis is associated with distinct histopathologic features on renal biopsy","volume":"92","author":"Turner-Stokes","year":"2017","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.autrev.2020.102618_bb0180","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015668","article-title":"Treatment and clinicopathological characteristics of lupus nephritis with anti-neutrophil cytoplasmic antibody positivity: a case-control study","volume":"7","author":"Li","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.autrev.2020.102618_bb0185","first-page":"1872846","article-title":"Anti-myeloperoxidase antibodies aassociate with future proliferative lupus nephritis","volume":"2017","author":"Olson","year":"2017","journal-title":"Autoimmune Dis"},{"issue":"2","key":"10.1016\/j.autrev.2020.102618_bb0190","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1445-5994.1992.tb02803.x","article-title":"Autoantibodies in systemic vasculitis","volume":"22","author":"Cohen Tervaert","year":"1992","journal-title":"Aust N Z J Med"},{"issue":"3","key":"10.1016\/j.autrev.2020.102618_bb0195","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1046\/j.1365-2249.2000.01325.x","article-title":"False-positive myeloperoxidase binding activity due to DNA\/anti-DNA antibody complexes: a source for analytical error in serologic evaluation of anti-neutrophil cytoplasmic autoantibodies","volume":"121","author":"Jethwa","year":"2000","journal-title":"Clin Exper Immunol"},{"issue":"10103","key":"10.1016\/j.autrev.2020.102618_bb0200","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.autrev.2020.102618_bb0205","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrrheum.2009.238","article-title":"Autoantibodies as predictive tools in systemic sclerosis","volume":"6","author":"Nihtyanova","year":"2010","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2020.102618_bb0210","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1365-2133.1996.23758.x","article-title":"Antineutrophil cytoplasmic autoantibodies in patients with systemic sclerosis","volume":"134","author":"Akimoto","year":"1996","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.autrev.2020.102618_bb0215","doi-asserted-by":"crossref","first-page":"866","DOI":"10.7326\/0003-4819-126-11-199706010-00003","article-title":"Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease","volume":"126","author":"Merkel","year":"1997","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.autrev.2020.102618_bb0220","first-page":"2666","article-title":"Antineutrophil cytoplasmic antibodies a \u201cred flag\u201d in patients with systemic sclerosis","volume":"29","author":"Casari","year":"2002","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2020.102618_bb0225","first-page":"918","article-title":"Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis","volume":"29","author":"Ruffatti","year":"2002","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.autrev.2020.102618_bb0230","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/rheumatology\/ket213","article-title":"Revisiting ANCA-associated vasculitis in systemic sclerosis: clinical, serological and immunogenetic factors","volume":"52","author":"Derrett-Smith","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.autrev.2020.102618_bb0235","doi-asserted-by":"crossref","first-page":"413","DOI":"10.5414\/CN109445","article-title":"ANCA-associated vasculitis in scleroderma: A renal perspective","volume":"90","author":"Kant","year":"2018","journal-title":"Clin Nephrol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102618_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0b013e31827781fd","article-title":"Systemic vasculitis during the course of systemic sclerosis","volume":"92","author":"Qu\u00e9m\u00e9neur","year":"2013","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.autrev.2020.102618_bb0245","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.semarthrit.2010.11.001","article-title":"Anti-neutrophil antibody associated vasculitis in systemic sclerosis","volume":"41","author":"Arad","year":"2011","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2020.102618_bb0250","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5414\/CNP68165","article-title":"ANCA-related crescentic glomerulonephritis in systemic sclerosis: revisiting the \u201cnormotensive scleroderma renal crisis\u201d","volume":"68","author":"Arnaud","year":"2007","journal-title":"Clin Nephrol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102618_bb0255","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13075-019-1839-5","article-title":"Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosis","volume":"21","author":"Moxey","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.autrev.2020.102618_bb0260","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.autrev.2015.04.009","article-title":"ANCA-associated vasculitis in patients with primary Sjogren\u2019s syndrome: detailed analysis of 7 new cases and systematic literature review","volume":"14","author":"Guellec","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.autrev.2020.102618_bb0265","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/rheumatology\/37.12.1287","article-title":"Antineutrophil cytoplasmic antibodies in primary Sj\u00f6gren\u2019s syndrome: prevalence and clinical significance","volume":"37","author":"Font","year":"1998","journal-title":"Br J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2020.102618_bb0270","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s100670050100","article-title":"Antineutrophil cytoplasmic antibody in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"18","author":"Nishiya","year":"1999","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2020.102618_bb0275","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.semarthrit.2005.12.004","article-title":"Atypical autoantibodies in patients with primary Sj\u00f6gren syndrome: clinical characteristics and follow-up of 82 cases","volume":"35","author":"Ramos-Casals","year":"2006","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2020.102618_bb0280","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1665-2681(19)30915-9","article-title":"Autoimmune liver disorders and small-vessel vasculitis: four case reports and review of the literature","volume":"13","author":"Tovoli","year":"2013","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.autrev.2020.102618_bb0285","first-page":"2017","article-title":"Autoimmune hepatitis and eosinophilic granulomatosis with polyangiitis: a rare association","volume":"20","author":"Lohani","year":"2017","journal-title":"BMJ Case Rep"},{"issue":"6","key":"10.1016\/j.autrev.2020.102618_bb0290","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.autrev.2020.102618_bb0295","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/gut.2008.157818","article-title":"p-ANCA in autoimmune liver disorders recognise human beta-tubulin isotype 5 and cross-react with microbial protein FtsZ","volume":"59","author":"Terjung","year":"2010","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.autrev.2020.102618_bb0300","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1136\/gut.2010.222646","article-title":"Immune reactivity to \u03b2-tubulin isotype 5 and vesicular integralmembrane protein 36 in patients with autoimmune gastrointestinal disorders","volume":"60","author":"Op De Beeck","year":"2011","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.autrev.2020.102618_bb0305","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.clinre.2012.07.008","article-title":"Antineutrophil cytoplasmic autoantibodies (ANCA) in autoimmune hepatitis and primary sclerosing cholangitis","volume":"37","author":"Deniziaut","year":"2013","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"6","key":"10.1016\/j.autrev.2020.102618_bb0310","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1478-3231.2009.01989.x","article-title":"What is behind the presence of antineutrophil cytoplasmatic antibodies in chronic liver disease?","volume":"29","author":"De Riva","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.autrev.2020.102618_bb0315","doi-asserted-by":"crossref","first-page":"18017","DOI":"10.1038\/nrdp.2018.17","article-title":"Autoimmune hepatitis","volume":"4","author":"Mieli-Vergani","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"10.1016\/j.autrev.2020.102618_bb0320","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/hep.510250510","article-title":"Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis","volume":"25","author":"Zauli","year":"1997","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.autrev.2020.102618_bb0325","first-page":"113","article-title":"Meyer Zum B\u00fcschenfelde KH, Mayet WJ. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity","volume":"35","author":"Orth","year":"1997","journal-title":"Z Gastroenterol"},{"issue":"5","key":"10.1016\/j.autrev.2020.102618_bb0330","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0168-8278(00)80241-X","article-title":"Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases","volume":"32","author":"Roozendaal","year":"2000","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.autrev.2020.102618_bb0335","first-page":"439","article-title":"Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis","volume":"9","author":"Terjung","year":"2004","journal-title":"Eur J Med Res"},{"issue":"5","key":"10.1016\/j.autrev.2020.102618_bb0340","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0002-9343(98)00294-0","article-title":"Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificities may be associated with distinct clinical features","volume":"105","author":"Roozendaal","year":"1998","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.autrev.2020.102618_bb0345","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1046\/j.1440-1746.2000.02078.x","article-title":"Anti-neutrophil cytoplasmic antibodies in patients with chronic liver diseases: prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease. Swedish Internal Medicine Liver Club (SILK)","volume":"15","author":"Lindgren","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.autrev.2020.102618_bb0350","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis - a comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J Hepatol"},{"issue":"24","key":"10.1016\/j.autrev.2020.102618_bb0355","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.3748\/wjg.14.3781","article-title":"Autoantibodies in primary sclerosing cholangitis","volume":"14","author":"Hov","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102618_bb0360","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1440-1746.1994.tb01214.x","article-title":"Anti-neutrophil cytoplasmic antibody: a prognostic indicator in primary sclerosing cholangitis","volume":"9","author":"Pokorny","year":"1994","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.autrev.2020.102618_bb0365","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/gut.38.3.384","article-title":"Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass","volume":"38","author":"Bansi","year":"1996","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.autrev.2020.102618_bb0370","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/liv.13238","article-title":"Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis","volume":"37","author":"Hov","year":"2017","journal-title":"Liver Int"},{"issue":"10","key":"10.1016\/j.autrev.2020.102618_bb0375","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3109\/00365521.2013.825313","article-title":"Antineutrophil cytoplasmic antibodies in bile are associated with disease activity in primary sclerosing cholangitis","volume":"48","author":"Lenzen","year":"2013","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102618_bb0380","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1053\/j.gastro.2008.11.033","article-title":"Antineutrophil cytoplasmic antibodies in small-duct primary sclerosing cholangitis","volume":"136","author":"Tervaert","year":"2009","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.autrev.2020.102618_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112877","article-title":"PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC)","volume":"9","author":"Stinton","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.autrev.2020.102618_bb0390","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.semarthrit.2015.07.006","article-title":"Vasculitis in patients with inflammatory bowel diseases: A study of 32 patients and systematic review of the literature","volume":"45","author":"Sy","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102618_bb0395","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.md.0000158825.87055.0b","volume":"84","author":"Pagnoux","year":"2005","journal-title":"Medicine"},{"issue":"12","key":"10.1016\/j.autrev.2020.102618_bb0400","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1172\/JCI104438","article-title":"Demonstration of circulating antinuclear globulins in ulcerative colitis","volume":"40","author":"Calabresi","year":"1961","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.autrev.2020.102618_bb0405","first-page":"783","article-title":"Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease","volume":"7","author":"Kossa","year":"1995","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.autrev.2020.102618_bb0410","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/ibd.21903","article-title":"Serological antibodies in inflammatory bowel disease: A systematic review","volume":"18","author":"Prideaux","year":"2012","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10.1016\/j.autrev.2020.102618_bb0415","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1373\/clinchem.2005.058560","article-title":"Serologic markers in inflammatory bowel disease","volume":"52","author":"Bossuyt","year":"2006","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.autrev.2020.102618_bb0420","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1128\/cdli.3.2.219-226.1996","article-title":"Specific antibody response to oligomannosidic epitopes in Crohn\u2019s disease","volume":"3","author":"Sendid","year":"1996","journal-title":"Clin Diagn Lab Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102618_bb0425","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/00365521.2018.1564361","article-title":"Changes in inflammatory bowel disease subtype during follow-up and over time in 44,302 patients","volume":"54","author":"Everhov","year":"2019","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"10.1016\/j.autrev.2020.102618_bb0430","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.crohns.2009.07.001","article-title":"Frequency of indeterminate colitis in children and adults with IBD \u2013 a metaanalysis","volume":"3","author":"Prenzel","year":"2009","journal-title":"J Crohns Colitis."},{"issue":"5","key":"10.1016\/j.autrev.2020.102618_bb0435","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1053\/gast.2002.32980","article-title":"The value of serologic markers in indeterminate colitis: a prospective follow-up study","volume":"122","author":"Joossens","year":"2002","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.autrev.2020.102618_bb0440","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1572-0241.2001.03613.x","article-title":"Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease","volume":"96","author":"Peeters","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.autrev.2020.102618_bb0445","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1097\/MIB.0000000000000784","article-title":"P-ANCA and ASCA in children with IBD-unclassified, Crohn\u2019s colitis, and ulcerative colitis \u2013 a longitudinal report from the IBD Porto Group of ESPGHAN","volume":"22","author":"Birimberg-Schwartz","year":"2016","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"10.1016\/j.autrev.2020.102618_bb0450","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/MCG.0000000000000083","article-title":"Characteristics of inflammatory bowel disease serology in patients with indeterminate colitis","volume":"48","author":"Sura","year":"2014","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"10.1016\/j.autrev.2020.102618_bb0455","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00054725-200011000-00002","article-title":"Anti-neutrophil cytoplasmic autoantibodies (ANCA) in ulcerative colitis (UC): no relationship with disease activity","volume":"6","author":"Reumaux","year":"2000","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"10.1016\/j.autrev.2020.102618_bb0460","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/qjmed\/92.11.651","article-title":"Titres of antineutrophil cytoplasmic antibodies in inflammatory bowel disease are not related to disease activity","volume":"92","author":"Roozendaal","year":"1999","journal-title":"QJM"},{"issue":"3","key":"10.1016\/j.autrev.2020.102618_bb0465","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/BF02088340","article-title":"Anti-neutrophil cytoplasmic antibodies (ANCA) in sera from patients with inflammatory bowel disease (IBD). Relation to disease pattern and disease activity","volume":"39","author":"Broekroelofs","year":"1994","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.autrev.2020.102618_bb0470","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/00365529850166905","article-title":"Long-term observation of the perinuclear anti-neutrophil cytoplasmic antibody status in ulcerative colitis patients","volume":"33","author":"Vecchi","year":"1998","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"10.1016\/j.autrev.2020.102618_bb0475","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.crohns.2007.10.001","article-title":"Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 years","volume":"2","author":"H\u00f8ie","year":"2008","journal-title":"J Crohns Colitis"},{"issue":"9","key":"10.1016\/j.autrev.2020.102618_bb0480","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1097\/MIB.0000000000000466","article-title":"Predictors of outcome in ulcerative colitis","volume":"21","author":"Waterman","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"10.1016\/j.autrev.2020.102618_bb0485","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1038\/ajg.2010.95","article-title":"Disease activity, ANCA, and IL23R genotype status determine early response to infliximab in patients with ulcerative colitis","volume":"105","author":"J\u00fcrgens","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.autrev.2020.102618_bb0490","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ibd.20054","article-title":"Predictors of early response to infliximab in patients with ulcerative colitis","volume":"13","author":"Ferrante","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2020.102618_bb0495","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1111\/j.1572-0241.2002.05689.x","article-title":"Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn\u2019s disease","volume":"97","author":"Esters","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2020.102618_bb0500","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1749-6632.2009.04752.x","article-title":"DNA-bound lactoferrin is the major target for antineutrophil perinuclear cytoplasmic antibodies in ulcerative colitis","volume":"1173","author":"Teegen","year":"2009","journal-title":"Ann N Y Acad Sci."},{"issue":"3","key":"10.1016\/j.autrev.2020.102618_bb0505","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194166","article-title":"Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patients","volume":"13","author":"Kovacs","year":"2018","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.autrev.2020.102618_bb0510","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12016-012-8349-4","article-title":"Presence of anti-proteinase 3 antineutrophil cytoplasmic antibodies (anti-PR3 ANCA) as serologic markers in inflammatory bowel disease","volume":"45","author":"Arias-Loste","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2020.102618_bb0515","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cca.2013.06.005","article-title":"PR3-ANCA: a promising biomarker for ulcerative colitis with extensive disease","volume":"424","author":"Mahler","year":"2013","journal-title":"Clin Chim Acta"},{"issue":"12","key":"10.1016\/j.autrev.2020.102618_bb0520","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208974","article-title":"PR3-ANCA and panel diagnostics in pediatric inflammatory bowel disease to distinguish ulcerative colitis from Crohn\u2019s disease","volume":"13","author":"Horn","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2020.102618_bb0525","doi-asserted-by":"crossref","first-page":"185416","DOI":"10.1155\/2014\/185416","article-title":"Novel clinical and diagnostic aspects of antineutrophil cytoplasmic antibodies","volume":"2014","author":"Schulte-Pelkum","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.autrev.2020.102618_bb0530","doi-asserted-by":"crossref","DOI":"10.1111\/jgh.14140","article-title":"Diagnostic and clinical role of serum proteinase 3 antineutrophil cytoplasmic antibodies in inflammatory bowel disease","author":"Takedatsu","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102618_bb0535","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1515\/cclm-2017-0346","article-title":"PR3-anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis","volume":"56","author":"Mahler","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.autrev.2020.102618_bb0540","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1023\/A:1019926121972","article-title":"Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac disease","volume":"22","author":"Damoiseaux","year":"2002","journal-title":"J Clin Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2020.102618_bb0545","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1055\/s-0038-1669413","article-title":"Antiglomerular basement membrane disease","volume":"39","author":"McAdoo","year":"2018","journal-title":"Semin Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.autrev.2020.102618_bb0550","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/ki.1990.72","article-title":"Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis","volume":"37","author":"Jayne","year":"1990","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.autrev.2020.102618_bb0555","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/j.1523-1755.2004.00917.x","article-title":"Clinical features and outcome of patients with both ANCA and anti-GBM antibodies","volume":"66","author":"Levy","year":"2004","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.autrev.2020.102618_bb0560","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000107803","article-title":"Characteristics and outcome of Chinese patients with both antineutrophil cytoplasmic antibody and antiglomerular basement membrane antibodies","volume":"107","author":"Zhao","year":"2007","journal-title":"Nephron Clin Pract"},{"issue":"3","key":"10.1016\/j.autrev.2020.102618_bb0565","doi-asserted-by":"crossref","first-page":"c59","DOI":"10.1159\/000072022","article-title":"The prognostic significance in Goodpasture\u2019s disease of specificity, titre and affinity of anti-glomerular-basement-membrane antibodies","volume":"94","author":"Segelmark","year":"2003","journal-title":"Nephron Clin Pract"},{"issue":"2","key":"10.1016\/j.autrev.2020.102618_bb0570","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/j.ajkd.2005.05.003","article-title":"Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis","volume":"46","author":"Rutgers","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.autrev.2020.102618_bb0575","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.kint.2017.03.014","article-title":"Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients","volume":"92","author":"McAdoo","year":"2017","journal-title":"Kidney Int"},{"issue":"05","key":"10.1016\/j.autrev.2020.102618_bb0580","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/ndt\/gfu399","article-title":"Predictors of renal and patient outcomes in anti-GBM disease: clinicopathologic analysis of a two-centre cohort","volume":"30","author":"Alchi","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.autrev.2020.102618_bb0585","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MD.0b013e31822f6f68","article-title":"Anti-glomerular basement membrane disease: outcomes of different therapeutic regimens in a large single-center Chinese cohort study","volume":"90","author":"Cui","year":"2011","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.autrev.2020.102618_bb0590","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2215\/CJN.04290417","article-title":"Predicting outcome in patients with anti-GBM glomerulonephritis","volume":"13","author":"van Daalen","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.autrev.2020.102618_bb0595","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1681\/ASN.2010090928","article-title":"Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease","volume":"22","author":"Olson","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"18","key":"10.1016\/j.autrev.2020.102618_bb0600","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1056\/NEJMoa0910500","article-title":"Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis","volume":"363","author":"Pedchenko","year":"2010","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.autrev.2020.102618_bb0605","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.kint.2016.12.012","article-title":"Deglycosylation of myeloperoxidase uncovers its novel antigenicity","volume":"91","author":"Yu","year":"2017","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.autrev.2020.102618_bb0610","first-page":"107","article-title":"Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease","volume":"36","author":"Bosch","year":"1991","journal-title":"Clin Nephrol"},{"issue":"9","key":"10.1016\/j.autrev.2020.102618_bb0615","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s10067-013-2268-5","article-title":"Characteristics and outcome of crescentic glomerulonephritis in patients with both antineutrophil cytoplasmic antibody and anti-glomerular basement membrane antibody","volume":"32","author":"Srivastava","year":"2013","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2020.102618_bb0620","first-page":"1695","article-title":"Autoantibodies to myeloperoxidase aggravate mild anti-glomerula basement membrane-mediated glomerular injury in the rat","volume":"149","author":"Heeringa","year":"1996","journal-title":"Am J Pathol"},{"issue":"8","key":"10.1016\/j.autrev.2020.102618_bb0625","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.2215\/CJN.13591215","article-title":"Spatial and temporal clustering of anti-glomerular basement membrane disease","volume":"11","author":"Canney","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102618_bb0630","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12882-018-1027-x","article-title":"Crescentic glomerulonephritis with anti-GBM antibody but no glomerular deposition","volume":"19","author":"Sadeghi-Alavijeh","year":"2018","journal-title":"BMC Nephrol"},{"issue":"3","key":"10.1016\/j.autrev.2020.102618_bb0635","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.kint.2017.04.024","article-title":"ANCA in anti-GBM disease: moving beyond a one-dimensional clinical phenotype","volume":"92","author":"Canney","year":"2017","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.autrev.2020.102618_bb0640","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.autrev.2020.102618_bb0645","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1183\/13993003.00150-2015","article-title":"An official European Respiratory Society\/American Thoracic Society research statement: interstitial pneumonia with autoimmune features","volume":"46","author":"Fischer","year":"2015","journal-title":"Europ Respir J"},{"issue":"4","key":"10.1016\/j.autrev.2020.102618_bb0650","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/art.40783","article-title":"Diagnostic pitfalls and treatment challenges in interstitial pneumonia with autoimmune features","volume":"71","author":"Novikov","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2020.102618_bb0655","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.autrev.2017.05.008","article-title":"Interstital lung disease in ANCA vasculitis","volume":"16","author":"Alba","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2020.102618_bb0660","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1055\/s-0038-1669914","article-title":"Antineutrophil cytoplasmic antibody-associated lung fibrosis","volume":"39","author":"Borie","year":"2018","journal-title":"Semin Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.autrev.2020.102618_bb0665","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ccm.2019.05.012","article-title":"Update on the management of respiratory manifestations of the antineutrophil cytoplasmic antibodies-associated vasculitides","volume":"40","author":"Thompson","year":"2019","journal-title":"Clin Chest Med"},{"issue":"3","key":"10.1016\/j.autrev.2020.102618_bb0670","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.39475","article-title":"Prevalence and responsiveness to treatment of lung abnormalities on chest computed tomography in patients with microscopic polyangiitis: A multicenter, longitudinal, retrospective study of one hundred fifty consecutive hospital-based Japanese patients","volume":"68","author":"Yamagata","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2020.102618_bb0675","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1093\/rheumatology\/ker236","article-title":"Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study","volume":"50","author":"Arulkumaran","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.autrev.2020.102618_bb0680","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1002\/art.39786","volume":"68","author":"Schirmer","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"10.1016\/j.autrev.2020.102618_bb0685","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3899\/jrheum.161224","article-title":"Pulmonary involvement in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: The influence of ANCA subtype","volume":"44","author":"Mohammad","year":"2017","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2020.102618_bb0690","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1186\/ar4550","article-title":"Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study","volume":"16","author":"Sada","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2020.102618_bb0695","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2214\/AJR.18.20967","article-title":"Chest high-resolution CT findings of microscopic polyangiitis: a Japanese first nationwide prospective cohort study","volume":"213","author":"Suzuki","year":"2019","journal-title":"Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102618_bb0700","article-title":"Antineutrophil cytoplasmic antibody-positive conversion and microscopic polyangiitis development in patients with idiopathic pulmonary fibrosis","volume":"2","author":"Kagiyama","year":"2015","journal-title":"BMJ Open Respir Res"},{"issue":"4","key":"10.1016\/j.autrev.2020.102618_bb0705","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.chest.2019.05.014","article-title":"Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in North American patients with idiopathic pulmonary fibrosis","volume":"156","author":"Liu","year":"2019","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.autrev.2020.102618_bb0710","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199659","article-title":"Clinical significance of myeloperoxidase-antineutrophil cytoplasmic antibody in idiopathic interstitial pneumonias","volume":"13","author":"Hozumi","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.autrev.2020.102618_bb0715","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00408-016-9851-x","article-title":"Clinical implication of proteinase-3-antineutrophil cytoplasmic antibody in patients with idiopathic interstitial pneumonias","volume":"194","author":"Hozumi","year":"2016","journal-title":"Lung"},{"issue":"6244","key":"10.1016\/j.autrev.2020.102618_bb0720","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1136\/bmj.281.6244.836","article-title":"Relapses in Wegener\u2019s granulomatosis: the role of infection","volume":"281","author":"Pinching","year":"1980","journal-title":"Br Med J"},{"issue":"3","key":"10.1016\/j.autrev.2020.102618_bb0725","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.autrev.2014.10.020","article-title":"Infections and antineutrophil cytoplasmic antibodies: triggering mechanisms","volume":"14","author":"Konstantinov","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.autrev.2020.102618_bb0730","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1093\/ndt\/gfl152","article-title":"Anti-neutrophil cytoplasmic antibody (ANCA)-associated microscopic polyangiitis following a suppurative wound infection","volume":"21","author":"Chan","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.autrev.2020.102618_bb0735","first-page":"783","article-title":"Antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis after immunisation with bacterial proteins","volume":"20","author":"Savige","year":"2002","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2020.102618_bb0740","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/ar392","article-title":"Staphylococcus aureus and Wegener\u2019s granulomatosis","volume":"4","author":"Popa","year":"2002","journal-title":"Arthritis Res"},{"issue":"1","key":"10.1016\/j.autrev.2020.102618_bb0745","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7326\/0003-4819-120-1-199401010-00003","article-title":"Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis","volume":"120","author":"Stegeman","year":"1994","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.autrev.2020.102618_bb0750","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJM199607043350103","article-title":"Trimethoprim\u2013sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener\u2019s granulomatosis. Dutch Co-Trimoxazole Wegener Study Group","volume":"335","author":"Stegeman","year":"1996","journal-title":"N Engl J Med."},{"issue":"Suppl. 4","key":"10.1016\/j.autrev.2020.102618_bb0755","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/2047-783X-14-S4-265","article-title":"Co-trimoxazole and prevention of relapses of PR3-ANCA positive vasculitis with pulmonary involvement","volume":"14","author":"Zycinska","year":"2009","journal-title":"Eur J Med Res"},{"issue":"4","key":"10.1016\/j.autrev.2020.102618_bb0760","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/BOR.0000000000000508","article-title":"Trimethoprim-sulfamethoxazole and antineutrophil cytoplasmic antibodies-associated vasculitis","volume":"30","author":"Cohen Tervaert","year":"2018","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2020.102618_bb0765","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/apm.12850","article-title":"High prevalence of a variety of autoantibodies in a population of hepatitis C virus-infected individuals","volume":"126","author":"Navarta","year":"2018","journal-title":"APMIS"},{"key":"10.1016\/j.autrev.2020.102618_bb0770","doi-asserted-by":"crossref","first-page":"982150","DOI":"10.1155\/2014\/982150","article-title":"Antineutrophil cytoplasmic antibody frequency in chronic hepatitis B patients","volume":"2014","author":"Calhan","year":"2014","journal-title":"Dis Markers"},{"issue":"2","key":"10.1016\/j.autrev.2020.102618_bb0775","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/rheumatology\/keg066","article-title":"Prevalence of antineutrophil cytoplasmic autoantibodies in patients with tuberculosis","volume":"42","author":"Flores-Su\u00e1rez","year":"2003","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.autrev.2020.102618_bb0780","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00296-014-3009-z","article-title":"Anti-PR3 and anti-MPO antibodies are not present in sera of patients with pulmonary tuberculosis","volume":"34","author":"Lima","year":"2014","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.autrev.2020.102618_bb0785","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/rheumatology\/keh467","article-title":"Low seroprevalence and poor specificity of antineutrophil cytoplasmic antibodies in tuberculosis","volume":"44","author":"Teixeira","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.autrev.2020.102618_bb0790","first-page":"283","article-title":"Spectrum of anti-neutrophil cytoplasmic antibodies in patients with pulmonary tuberculosis overlaps with that of Wegener\u2019s granulomatosis","volume":"58","author":"Pradhan","year":"2004","journal-title":"Indian J Med Sci"},{"issue":"6","key":"10.1016\/j.autrev.2020.102618_bb0795","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1002\/art.38389","article-title":"IMAGE Study Group. Brief report: prevalence of antineutrophil cytoplasmic antibodies in infective endocarditis","volume":"66","author":"Mahr","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2020.102618_bb0800","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089777","article-title":"Infective endocarditis with antineutrophil cytoplasmic antibody: report of 13 cases and literature review","volume":"9","author":"Ying","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.autrev.2020.102618_bb0805","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002564","article-title":"Antineutrophil cytoplasmic antibodies associated with infective endocarditis","volume":"95","author":"Langlois","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.autrev.2020.102618_bb0810","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/ki.2014.424","article-title":"Update on endocarditis-associated glomerulonephritis","volume":"87","author":"Boils","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2020.102618_bb0815","first-page":"9607582","article-title":"Bartonella endocarditis mimicking crescentic glomerulonephritis with PR3-ANCA positivity","volume":"2018","author":"Vercellone","year":"2018","journal-title":"Case Rep Nephrol"},{"issue":"3","key":"10.1016\/j.autrev.2020.102618_bb0820","first-page":"208","article-title":"Bacterial endocarditis associated with proteinase 3 anti-neutrophil cytoplasm antibody","volume":"4","author":"McAdoo","year":"2011","journal-title":"NDT Plus"},{"issue":"6","key":"10.1016\/j.autrev.2020.102618_bb0825","doi-asserted-by":"crossref","first-page":"431","DOI":"10.5414\/CN109495","article-title":"Bacterial endocarditis manifesting as autoimmune pulmonary renal syndrome: ANCA-associated lung hemorrhage and pauci-immune crescentic glomerulonephritis","volume":"90","author":"Mohandes","year":"2018","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.autrev.2020.102618_bb0830","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5414\/CNCS109076","article-title":"ANCA-associated pauci-immune glomerulonephritis in a patient with bacterial endocarditis: a challenging clinical dilemma","volume":"5","author":"Cervi","year":"2017","journal-title":"Clin Nephrol Case Stud"},{"issue":"1","key":"10.1016\/j.autrev.2020.102618_bb0835","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2249.1992.tb06408.x","article-title":"Anti-neutrophil cytoplasmic autoantibodies in patients with symptomatic HIV infection","volume":"87","author":"Klaassen","year":"1992","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2020.102618_bb0840","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006230","article-title":"Nonorgan-specific autoantibodies in HIV-infected patients in the HAART era","volume":"96","author":"Iordache","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.autrev.2020.102618_bb0845","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/RHU.0b013e3181b55fe4","article-title":"ANCA-associated vasculitis following influenza vaccination: causal association or mere coincidence?","volume":"15","author":"Birck","year":"2009","journal-title":"J Clin Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2020.102618_bb0850","doi-asserted-by":"crossref","first-page":"892","DOI":"10.2169\/internalmedicine.44.892","article-title":"Microscopic polyangiitis after influenza vaccination","volume":"44","author":"Uji","year":"2005","journal-title":"Intern Med"},{"issue":"2","key":"10.1016\/j.autrev.2020.102618_bb0855","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000354084","article-title":"Antineutrophil cytoplasmic antibody vasculitis associated with influenza vaccination","volume":"38","author":"Duggal","year":"2013","journal-title":"Am J Nephrol"},{"issue":"8","key":"10.1016\/j.autrev.2020.102618_bb0860","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1440-1797.2010.01375.x","article-title":"Influenza A H1N1, microscopic polyangiitis and pulmonary haemorrhage","volume":"15","author":"Jolly","year":"2010","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.autrev.2020.102618_bb0865","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1093\/ndt\/gfp398","article-title":"Influenza vaccination in ANCA-associated vasculitis","volume":"24","author":"Spaetgens","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.autrev.2020.102618_bb0870","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10067-015-3073-0","article-title":"Viral RNA in the influenza vaccine may have contributed to the development of ANCA-associated vasculitis in a patient following immunisation","volume":"35","author":"Jeffs","year":"2015","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2020.102618_bb0875","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10067-017-3748-9","article-title":"The autoimmune\/inflammatory syndrome induced by adjuvants (ASIA)\/Shoenfeld\u2019s syndrome: descriptive analysis of 300 patients from the international ASIA syndrome registry","volume":"37","author":"Watad","year":"2018","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2020.102618_bb0880","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126016","article-title":"Incidence of cancer in ANCA-associated vasculitis: a meta-analysis of observational studies","volume":"10","author":"Shang","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.autrev.2020.102618_bb0885","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/BOR.0000000000000448","article-title":"Antineutrophil cytoplasmic antibody-associated vasculitis and malignancy","volume":"30","author":"Wester Trejo","year":"2018","journal-title":"Curr Opin Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2020.102618_bb0890","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/rheumatology\/keh374","article-title":"Malignancy is increased in ANCA-associated vasculitis","volume":"43","author":"Pankhurst","year":"2004","journal-title":"Rheumatology (Oxford)."},{"issue":"4","key":"10.1016\/j.autrev.2020.102618_bb0895","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/1529-0131(199904)42:4<751::AID-ANR19>3.0.CO;2-D","article-title":"Wegener\u2019s granulomatosis associated with renal cell carcinoma","volume":"42","author":"Tatsis","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2020.102618_bb0900","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3899\/jrheum.160885","article-title":"Incidence of malignancy prior to antineutrophil cytoplasmic antibody-associated vasculitis compared to the general population","volume":"44","author":"van Daalen","year":"2017","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102618_bb0905","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jbspin.2016.01.012","article-title":"Antineutrophilic cytoplasmic antibody-associated vasculitis and malignant hemopathies, a retrospective study of 16 cases","volume":"84","author":"Philipponnet","year":"2017","journal-title":"Joint Bone Spine"},{"issue":"8","key":"10.1016\/j.autrev.2020.102618_bb0910","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/art.23085","article-title":"Vasculitides associated with malignancies: analysis of sixty patients","volume":"57","author":"Fain","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2020.102618_bb0915","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1445-5994.1994.tb02173.x","article-title":"Anti-neutrophil cytoplasmic antibodies (ANCA) in myelodysplasia and other haematological disorders","volume":"24","author":"Savige","year":"1994","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.autrev.2020.102618_bb0920","doi-asserted-by":"crossref","first-page":"1732175","DOI":"10.1155\/2019\/1732175","article-title":"ANCA-associated vasculitides and hematologic malignancies: lessons from the past and future perspectives","volume":"2019","author":"Folci","year":"2019","journal-title":"J Immunol Res"},{"issue":"2","key":"10.1016\/j.autrev.2020.102618_bb0925","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1189\/jlb.69.2.177","article-title":"Proteinase 3, Wegener\u2019s autoantigen: from gene to antigen","volume":"69","author":"van der Geld","year":"2001","journal-title":"J Leukoc Biol"},{"issue":"2","key":"10.1016\/j.autrev.2020.102618_bb0930","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-2141.1995.tb03297.x","article-title":"Immuno-cytochemical and flow cytometric detection of proteinase 3 (myeloblastin) in normal and leukaemic myeloid cells","volume":"89","author":"Dengler","year":"1995","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.autrev.2020.102618_bb0935","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1172\/JCI200316398","article-title":"Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells","volume":"111","author":"Molldrem","year":"2003","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.autrev.2020.102618_bb0940","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/RHU.0b013e31826d2005","article-title":"Proteinase-3 antineutrophil cytoplasm antibody positivity in patients without primary systemic vasculitis","volume":"18","author":"McAdoo","year":"2012","journal-title":"J Clin Rheumatol"},{"issue":"40","key":"10.1016\/j.autrev.2020.102618_bb0945","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005096","article-title":"Diagnosing ANCA-associated vasculitis in ANCA positive patients: A retrospective analysis on the role of clinical symptoms and the ANCA titre","volume":"95","author":"Houben","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.autrev.2020.102618_bb0950","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12185-009-0341-2","article-title":"Prevalence of antineutrophil cytoplasmic antibody positivity in patients with Hodgkin\u2019s and non-Hodgkin lymphoma: a single center experience","volume":"90","author":"Cil","year":"2009","journal-title":"Int J Hematol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102618_bb0955","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/14397595.2016.1205798","article-title":"Intravascular large B-cell lymphoma with a high titer of proteinase-3-anti-neutrophil cytoplasmic antibody mimicking granulomatosis with polyangiitis","volume":"29","author":"Shinkawa","year":"2019","journal-title":"Mod Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2020.102618_bb0960","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/s10165-010-0361-z","article-title":"A patient with intravascular lymphoma presenting with cerebral infarction and a high serum MPO-ANCA level","volume":"21","author":"Muto","year":"2011","journal-title":"Mod Rheumatol"},{"issue":"23","key":"10.1016\/j.autrev.2020.102618_bb0965","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.2169\/internalmedicine.48.2600","article-title":"Peripheral T cell lymphoma with a high titer of proteinase-3-antineutrophil cytoplasmic antibodies that resembled Wegener\u2019s granulomatosis","volume":"48","author":"Shirai","year":"2009","journal-title":"Intern Med"},{"issue":"10","key":"10.1016\/j.autrev.2020.102618_bb0970","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/rheumatology\/ken321","article-title":"Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis","volume":"47","author":"Gao","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.autrev.2020.102618_bb0975","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1440-1797.2009.01100.x","article-title":"Review article: Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"14","author":"Gao","year":"2009","journal-title":"Nephrology"},{"issue":"1","key":"10.1016\/j.autrev.2020.102618_bb0980","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/BOR.0b013e3283323538","article-title":"Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis","volume":"22","author":"Csernok","year":"2010","journal-title":"Curr Opin Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2020.102618_bb0985","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nrneph.2012.108","article-title":"Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis","volume":"8","author":"Chen","year":"2012","journal-title":"Nat Rev Nephrol"},{"issue":"10","key":"10.1016\/j.autrev.2020.102618_bb0990","doi-asserted-by":"crossref","first-page":"804","DOI":"10.5414\/CP202576","article-title":"Rifampicin-induced antineutrophil cytoplasmic antibody-positive vasculitis: a case report and review of the literature","volume":"54","author":"Ji","year":"2016","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.autrev.2020.102618_bb0995","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/BOR.0000000000000014","article-title":"Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis","volume":"26","author":"Pendergraft","year":"2014","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2020.102618_bb1000","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.semarthrit.2018.01.005","article-title":"Hydralazine-associated vasculitis: Overlapping features of drug-induced lupus and vasculitis","volume":"48","author":"Kumar","year":"2018","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.autrev.2020.102618_bb1005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11926-016-0588-6","article-title":"Biological therapy-induced systemic vasculitis","volume":"18","author":"Guti\u00e9rrez-Gonz\u00e1lez","year":"2016","journal-title":"Curr Rheumatol Rep"},{"issue":"12","key":"10.1016\/j.autrev.2020.102618_bb1010","first-page":"1164","article-title":"Adverse events associated with immune checkpoint blockade","volume":"378","author":"Cohen Tervaert","year":"2018","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.autrev.2020.102618_bb1015","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1089\/thy.2014.0603","article-title":"Antineutrophil cytoplasmic antibody-positive small-vessel vasculitis associated with antithyroid drug therapy: how significant is the clinical problem?","volume":"25","author":"Balavoine","year":"2015","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.autrev.2020.102618_bb1020","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/art.20927","article-title":"Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs: A long-term followup study","volume":"53","author":"Slot","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.autrev.2020.102618_bb1025","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1002\/art.20479","article-title":"Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis","volume":"50","author":"Wiesner","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2020.102618_bb1030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.autrev.2017.11.011","article-title":"Cocaine and ANCA associated vasculitis-like syndromes - A case series","volume":"17","author":"Subesinghe","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2020.102618_bb1035","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3892\/etm.2016.3349","article-title":"Anti-neutrophil cytoplasmic antibodies in cholesterol embolism: A case report and literature review","volume":"12","author":"Zhang","year":"2016","journal-title":"Exp Ther Med"},{"issue":"8","key":"10.1016\/j.autrev.2020.102618_bb1040","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/ard.62.8.780","article-title":"An unusual case of ANCA positive disease","volume":"62","author":"Delen","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.autrev.2020.102618_bb1045","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2169\/internalmedicine.45.0152","article-title":"ANCA in atheroembolism; just a coincidence or bearing cause and effect?","volume":"45","author":"Minota","year":"2006","journal-title":"Intern Med"},{"issue":"1","key":"10.1016\/j.autrev.2020.102618_bb1050","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1365-2796.2002.00920.x","article-title":"Antineutrophil cytoplasmatic antibodies in patients with premature atherosclerosis: Prevalence and association with risk factors","volume":"251","author":"van Haelst","year":"2002","journal-title":"J Intern Med"},{"issue":"2","key":"10.1016\/j.autrev.2020.102618_bb1055","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1089\/ped.2018.0970","article-title":"Prevalence of bactericidal\/permeability-increasing protein autoantibodies in cystic fibrosis patients: Systematic review and meta-analysis","volume":"32","author":"Iwuji","year":"2019","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"issue":"4","key":"10.1016\/j.autrev.2020.102618_bb1060","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/qjmed\/89.4.259","article-title":"Autoantibodies against bactericidal\/permeability-increasing protein in patients with cystic fibrosis","volume":"89","author":"Zhao","year":"1996","journal-title":"QJM"},{"issue":"3","key":"10.1016\/j.autrev.2020.102618_bb1065","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jcf.2006.10.005","article-title":"Autoantibody response to BPI predict disease severity and outcome in cystic fibrosis","volume":"6","author":"Carlsson","year":"2007","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.autrev.2020.102618_bb1070","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s002960050116","article-title":"Clinical associations and characterisation of antineutrophil cytoplasmic antibodies directed against bactericidal\/permeability-increasing protein and azurocidin","volume":"19","author":"Cooper","year":"2000","journal-title":"Rheumatol Int"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2020.102618_bb1075","article-title":"Relapsing polychondritis: state of the art on clinical practice guidelines","volume":"4","author":"Rednic","year":"2018","journal-title":"RMD Open"},{"issue":"34","key":"10.1016\/j.autrev.2020.102618_bb1080","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004633","article-title":"Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: A case report and review of the literature","volume":"95","author":"Della-Torre","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1016\/j.autrev.2020.102618_bb1085","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/1756-185X.13693","article-title":"Do ANCA-associated vasculitides and IgG4-related disease really overlap or not?","volume":"22","author":"Erden","year":"2019","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2020.102618_bb1090","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.autrev.2017.12.003","article-title":"Comment on the article entitled \u201cAntineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndrome\u201d","volume":"17","author":"Goulabchand","year":"2018","journal-title":"Autoimmun Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220301853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220301853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:18:59Z","timestamp":1761599939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997220301853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":218,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1568997220301853"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102618","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2020 international consensus on ANCA testing beyond systemic vasculitis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102618","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102618"}}